ASX:PME

Pro Medicus Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume285,954 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.30%
BetaN/A

Competitors

Pro Medicus (ASX:PME) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying PME stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to Pro Medicus, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

Pro Medicus (ASX:PME) and 1st Group (ASX:1ST) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Valuation and Earnings

This table compares Pro Medicus and 1st Group's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro Medicus$59.12 million0.00$24.49 millionA$0.24N/A
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A

Pro Medicus has higher revenue and earnings than 1st Group.

Analyst Ratings

This is a summary of current ratings and price targets for Pro Medicus and 1st Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus0000N/A
1st Group0000N/A

Profitability

This table compares Pro Medicus and 1st Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
1st GroupN/AN/AN/A

Summary

Pro Medicus beats 1st Group on 3 of the 3 factors compared between the two stocks.

Pro Medicus (ASX:PME) and Alcidion Group (ASX:ALC) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

Valuation & Earnings

This table compares Pro Medicus and Alcidion Group's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro Medicus$59.12 million0.00$24.49 millionA$0.24N/A
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A

Pro Medicus has higher revenue and earnings than Alcidion Group.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Pro Medicus and Alcidion Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus0000N/A
Alcidion Group0000N/A

Profitability

This table compares Pro Medicus and Alcidion Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
Alcidion GroupN/AN/AN/A

Summary

Pro Medicus beats Alcidion Group on 3 of the 3 factors compared between the two stocks.

Binovi Technologies (OTCMKTS:BNVIF) and Pro Medicus (ASX:PME) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Valuation and Earnings

This table compares Binovi Technologies and Pro Medicus' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Binovi TechnologiesN/AN/AN/AN/AN/A
Pro Medicus$59.12 million0.00$24.49 millionA$0.24N/A

Pro Medicus has higher revenue and earnings than Binovi Technologies.

Profitability

This table compares Binovi Technologies and Pro Medicus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Binovi TechnologiesN/AN/AN/A
Pro MedicusN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings for Binovi Technologies and Pro Medicus, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Binovi Technologies0000N/A
Pro Medicus0000N/A

Summary

Pro Medicus beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Cann American (CNSX:CNNA) and Pro Medicus (ASX:PME) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership.

Valuation & Earnings

This table compares Cann American and Pro Medicus' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cann AmericanN/AN/AN/AN/AN/A
Pro Medicus$59.12 million0.00$24.49 millionA$0.24N/A

Pro Medicus has higher revenue and earnings than Cann American.

Profitability

This table compares Cann American and Pro Medicus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cann AmericanN/AN/AN/A
Pro MedicusN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Cann American and Pro Medicus, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cann American0000N/A
Pro Medicus0000N/A

Summary

Pro Medicus beats Cann American on 1 of the 1 factors compared between the two stocks.

Pro Medicus (ASX:PME) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Profitability

This table compares Pro Medicus and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and target prices for Pro Medicus and CannaOne Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus0000N/A
CannaOne Technologies0000N/A

Valuation and Earnings

This table compares Pro Medicus and CannaOne Technologies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro Medicus$59.12 million0.00$24.49 millionA$0.24N/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

Pro Medicus has higher revenue and earnings than CannaOne Technologies.

Summary

Pro Medicus beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and Pro Medicus (ASX:PME) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Valuation & Earnings

This table compares CloudMD Software & Services and Pro Medicus' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
Pro Medicus$59.12 million0.00$24.49 millionA$0.24N/A

Pro Medicus has higher revenue and earnings than CloudMD Software & Services.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for CloudMD Software & Services and Pro Medicus, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
Pro Medicus0000N/A

CloudMD Software & Services currently has a consensus price target of $3.3750, indicating a potential upside of 110.28%.

Profitability

This table compares CloudMD Software & Services and Pro Medicus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
Pro MedicusN/AN/AN/A


Pro Medicus Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Gap Down
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.01flat$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.61flat$0.00N/A0.00Gap Up
DOC
CloudMD Software & Services
1.2$2.01flatC$0.00C$11.65 million-22.33
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Gap Down
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00
FORA
Forian
0.3$12.05flat$0.00N/A0.00
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.41flat$0.00N/A0.00Gap Up
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.20flat$0.00N/A0.00News Coverage
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65flat$0.00N/A0.00
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.73flat$0.00N/A0.00High Trading Volume
Gap Down
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00Gap Down
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$5.88flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.